# BreStem Therapeutics, Inc. — Form D/A

BreStem Therapeutics, Inc. of RALEIGH, NC, a company, filed a Form D amendment with the SEC on 2021-11-24. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2021-11-24
- Form: D/A
- Accession: 0001723963-21-000005
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 3
- Date of first sale: 2021-06-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-405341

## Issuer

- Name: BreStem Therapeutics, Inc.
- CIK: 0001723963
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Incorporated: 2017
- Address: 1001 WILLIAM MOORE DRIVE, RALEIGH, NC, 27606
- Phone: 919-513-6157

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Ke Cheng | Director | RALEIGH, NC |
| Weigang Wang | Director | RALEIGH, NC |
| Weili Zhou | Director | RALEIGH, NC |
| Ke Cheng | Executive Officer | RALEIGH, NC |
| Dongmei Zhu | Executive Officer | Raleigh, NC |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-07-06](https://search.stillhousedata.com/formd/0001723963-21-000004) | D | $2.0M | $250K |
| [2017-11-29](https://search.stillhousedata.com/formd/0001723963-17-000001) | D | $2.0M | $50K |

## More

- [CIK 1723963 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1723963&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001723963-21-000005.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.